| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| RAPT Therapeutics, Inc. | Director | Common Stock | 4,956 | $167,875 | $33.87 | 30 Jan 2026 | Direct |
| RAPT Therapeutics, Inc. | Director | Director Stock Option (right to buy) | 257,832 | 29 May 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RAPT | RAPT Therapeutics, Inc. | 30 Jan 2026 | 1 | $0 | 4 | Director | 02 Feb 2026, 17:45 |
| RAPT | RAPT Therapeutics, Inc. | 29 May 2025 | 1 | $0 | 4 | Director | 02 Jun 2025, 16:59 |
| RAPT | RAPT Therapeutics, Inc. | 22 May 2024 | 1 | $0 | 4 | Director | 23 May 2024, 18:14 |
| RAPT | RAPT Therapeutics, Inc. | 24 May 2023 | 1 | $0 | 4 | Director | 25 May 2023, 18:54 |
| RAPT | RAPT Therapeutics, Inc. | 25 May 2022 | 1 | $0 | 4 | Director | 26 May 2022, 18:08 |
| RAPT | RAPT Therapeutics, Inc. | 28 May 2021 | 1 | $0 | 4 | Director | 24 Jun 2021, 20:19 |